|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1341 G street NW Flr 5 |
Address2 |
|
City | WASHINGTON |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 61458-1406
|
||||||||
|
6. House ID# 353940050
|
TYPE OF REPORT | 8. Year | 2019 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Robert Raben |
Date | 1/20/2020 12:00:33 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HOUSE AND SENATE APPROPRIATIONS
The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following:
Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network
Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program
National Institute of Environmental Health Sciences (NIEHS)
CURRENT LEGISLATIVE PROPOSALS:
Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system and is working to ensure strong, health-protective measures are included in any proposed legislation. This includes H.R. 4296, the Safe Cosmetics and Personal Care Products Act of 2019, S.726, the Personal Care Products Safety Act, and any other legislation that would impact the regulation of personal care products.
FUTURE LEGISLATIVE PROPOSALS:
Breast Cancer Prevention Partners visits Congressional offices to oppose legislative proposals that undermine transparency for consumers and undermine
states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer products.
Breast Cancer Prevention Partners supports efforts to reintroduce legislation that establishes environmental justice as a consideration in the regulation of
pesticides and personal care products.
Breast Cancer Prevention Partners supports efforts to reintroduce legislation that would ban food containers composed, in whole or in part, of bisphenol A
(BPA).
Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their
health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products.
Breast Cancer Prevention Partners supports efforts to increase federal funding for research and to regulate per- and polyfluoroalkyl substances (PFAS).
Breast Cancer Prevention Partners supports legislation that would strengthen public health restrictions and set new standards on ethylene oxide emissions.
Breast Cancer Prevention Partners supports legislation that increases transparency and addresses personal care products labeled or packaged as "natural".
REGULATION AND LEGISLATIVE INTENT:
P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act - The Breast Cancer Prevention Partners is working to support and
encourage strong, health-protective implementation of the reforms enacted in the Toxic Substances Control Act (TSCA).
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Consumer Product Safety Commission (CPSC), Natl Institutes of Health (NIH), Environmental Protection Agency (EPA), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katharine |
Huffman |
|
|
|
Abigail |
Omojola |
|
|
|
Diego |
Sanchez Gallardo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CHM
16. Specific lobbying issues
HOUSE AND SENATE APPROPRIATIONS
The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following:
Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network
Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program
National Institute of Environmental Health Sciences (NIEHS)
CURRENT LEGISLATIVE PROPOSALS:
Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system and is working to ensure strong, health-protective measures are included in any proposed legislation. This includes H.R. 4296, the Safe Cosmetics and Personal Care Products Act of 2019, S.726, the Personal Care Products Safety Act, and any other legislation that would impact the regulation of personal care products.
FUTURE LEGISLATIVE PROPOSALS:
Breast Cancer Prevention Partners visits Congressional offices to oppose legislative proposals that undermine transparency for consumers and undermine
states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer products.
Breast Cancer Prevention Partners supports efforts to reintroduce legislation that establishes environmental justice as a consideration in the regulation of
pesticides and personal care products.
Breast Cancer Prevention Partners supports efforts to reintroduce legislation that would ban food containers composed, in whole or in part, of bisphenol A
(BPA).
Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their
health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products.
Breast Cancer Prevention Partners supports efforts to increase federal funding for research and to regulate per- and polyfluoroalkyl substances (PFAS).
Breast Cancer Prevention Partners supports legislation that would strengthen public health restrictions and set new standards on ethylene oxide emissions.
Breast Cancer Prevention Partners supports legislation that increases transparency and addresses personal care products labeled or packaged as "natural".
REGULATION AND LEGISLATIVE INTENT:
P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act - The Breast Cancer Prevention Partners is working to support and
encourage strong, health-protective implementation of the reforms enacted in the Toxic Substances Control Act (TSCA).
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Consumer Product Safety Commission (CPSC), Natl Institutes of Health (NIH), Environmental Protection Agency (EPA), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katharine |
Huffman |
|
|
|
Abigail |
Omojola |
|
|
|
Diego |
Sanchez Gallardo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
HOUSE AND SENATE APPROPRIATIONS
The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following:
Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network
Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program
National Institute of Environmental Health Sciences (NIEHS)
CURRENT LEGISLATIVE PROPOSALS:
Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system and is working to ensure strong, health-protective measures are included in any proposed legislation. This includes H.R. 4296, the Safe Cosmetics and Personal Care Products Act of 2019, S.726, the Personal Care Products Safety Act, and any other legislation that would impact the regulation of personal care products.
FUTURE LEGISLATIVE PROPOSALS:
Breast Cancer Prevention Partners visits Congressional offices to oppose legislative proposals that undermine transparency for consumers and undermine
states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer products.
Breast Cancer Prevention Partners supports efforts to reintroduce legislation that establishes environmental justice as a consideration in the regulation of
pesticides and personal care products.
Breast Cancer Prevention Partners supports efforts to reintroduce legislation that would ban food containers composed, in whole or in part, of bisphenol A
(BPA).
Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their
health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products.
Breast Cancer Prevention Partners supports efforts to increase federal funding for research and to regulate per- and polyfluoroalkyl substances (PFAS).
Breast Cancer Prevention Partners supports legislation that would strengthen public health restrictions and set new standards on ethylene oxide emissions.
Breast Cancer Prevention Partners supports legislation that increases transparency and addresses personal care products labeled or packaged as "natural".
REGULATION AND LEGISLATIVE INTENT:
P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act - The Breast Cancer Prevention Partners is working to support and
encourage strong, health-protective implementation of the reforms enacted in the Toxic Substances Control Act (TSCA).
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Consumer Product Safety Commission (CPSC), Natl Institutes of Health (NIH), Environmental Protection Agency (EPA), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katharine |
Huffman |
|
|
|
Abigail |
Omojola |
|
|
|
Diego |
Sanchez Gallardo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
HOUSE AND SENATE APPROPRIATIONS
The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following:
Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network
Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program
National Institute of Environmental Health Sciences (NIEHS)
CURRENT LEGISLATIVE PROPOSALS:
Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system and is working to ensure strong, health-protective measures are included in any proposed legislation. This includes H.R. 4296, the Safe Cosmetics and Personal Care Products Act of 2019, S.726, the Personal Care Products Safety Act, and any other legislation that would impact the regulation of personal care products.
FUTURE LEGISLATIVE PROPOSALS:
Breast Cancer Prevention Partners visits Congressional offices to oppose legislative proposals that undermine transparency for consumers and undermine
states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer products.
Breast Cancer Prevention Partners supports efforts to reintroduce legislation that establishes environmental justice as a consideration in the regulation of
pesticides and personal care products.
Breast Cancer Prevention Partners supports efforts to reintroduce legislation that would ban food containers composed, in whole or in part, of bisphenol A
(BPA).
Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their
health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products.
Breast Cancer Prevention Partners supports efforts to increase federal funding for research and to regulate per- and polyfluoroalkyl substances (PFAS).
Breast Cancer Prevention Partners supports legislation that would strengthen public health restrictions and set new standards on ethylene oxide emissions.
Breast Cancer Prevention Partners supports legislation that increases transparency and addresses personal care products labeled or packaged as "natural".
REGULATION AND LEGISLATIVE INTENT:
P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act - The Breast Cancer Prevention Partners is working to support and
encourage strong, health-protective implementation of the reforms enacted in the Toxic Substances Control Act (TSCA).
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Consumer Product Safety Commission (CPSC), Natl Institutes of Health (NIH), Environmental Protection Agency (EPA), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katharine |
Huffman |
|
|
|
Abigail |
Omojola |
|
|
|
Diego |
Sanchez Gallardo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |